Human Papillomavirus Vaccine Coverage Among Females Aged 11 to 17 in Texas Counties: An Application of Multilevel, Small Area Estimation

Women's Health Issues

Volumn 23, Issue 2, 2013, Pages

  Eberth, Jan M ^a   Hossain, Md Monir ^b   Tiro, Jasmin A ^c   Zhang, Xingyou ^d   Holt, James B ^d   Vernon, Sally W ^e  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE IMMUNIZATION; ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; EDUCATION PROGRAM; ETHNICITY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE SURVEY; HUMAN; POVERTY; PUBLIC HEALTH; REGIONALIZATION; SCHOOL CHILD; SMALL AREA ESTIMATION; STATISTICAL CONCEPTS; UNITED STATES;

ADOLESCENT; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; CHILD; FEMALE; HEALTH BEHAVIOR; HEALTH CARE SURVEYS; HUMANS; IMMUNIZATION PROGRAMS; LOGISTIC MODELS; MULTILEVEL ANALYSIS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; POPULATION SURVEILLANCE; POVERTY; SMALL-AREA ANALYSIS; SOCIOECONOMIC FACTORS; TEXAS; VACCINATION;

EID: 84875386539     PISSN: 10493867     EISSN: 18784321     Source Type: Journal    
DOI: 10.1016/j.whi.2012.12.005     Document Type: Article

References (32)

1. Carle A.C. Fitting multilevel models in complex survey data with design weights: Recommendations. BMC Medical Research Methodology 2009, 9:49.
2. Chao C., Velicer C., Slezak J.M., Jacobsen S.J. Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization. Mayo Clinic Proceedings 2009, 84:864-870.
3. Chao C., Velicer C., Slezak J.M., Jacobsen S.J. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. American Journal of Epidemiology 2010, 171:357-367.
4. Congdon P. A multilevel model for cardiovascular disease prevalence in the US and its application to micro area prevalence estimates. International Journal of Health Geographics 2009, 8:6.
5. Congdon P. A multilevel model for comorbid outcomes: Obesity and diabetes in the US. International Journal of Environmental Research and Public Health 2010, 7:333-352.
6. Conroy K., Rosenthal S.L., Zimet G.D., Yan J., Bernstein D.I., Glynn S., et al. Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. Journal of Women's Health 2009, 18:1679-1686.
7. Dempsey A., Cohn L., Dalton V., Ruffin M. Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. Vaccine 2010, 28:989-995.
8. Dorell C., Stokley S., Yankey D., Cohn A., Markowitz L. National, state, and local area vaccination coverage among adolescents aged 13-17 years: United States, 2009. Morbidity & Mortality Weekly Report 2010, 59:1018-1023.
9. Dorell C., Stokley S., Yankey D., Liang J.L., Markowitz L. National and state vaccination coverage among adolescents aged 13 through 17 years: United States, 2010. Morbidity and Mortality Weekly Report 2011, 60:1117-1123.
10. Goldstein H. Multilevel statistical models 2010, John Wiley & Sons, Ltd., West Sussex, UK. 4th ed.
11. Goodman M.S. Comparison of small-area analysis techniques for estimating prevalence by race. Preventing Chronic Disease 2010, 7. A33.
12. Gottlieb S.L., Brewer N.T., Sternberg M.R., Smith J.S., Ziarnowski K., Liddon N., et al. Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer. Journal of Adolescent Health 2009, 45:430-437.
13. Hosmer D.W., Lemeshow S. Applied logistic regression 2000, John Wiley & Sons, Inc, Hoboken, NJ. 2nd ed.
14. Jain N., Stokley S., Yankey D. Vaccination coverage among adolescents aged 13-17 years: United States, 2007. Morbidity & Mortality Weekly Report 2008, 57:1100-1103.
15. Jia H., Muennig P., Borawski E. Comparison of small-area analysis techniques for estimating county-level outcomes. American Journal of Preventive Medicine 2004, 26:453-460.
16. Kahn J.A., Rosenthal S.L., Jin Y., Huang B., Namakydoust A., Zimet G.D. Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstetrics and Gynecology 2008, 111:1103-1110.
17. Li W., Land T., Zi Z., Keithly L., Kelsey J.L. Small-area estimation and prioritizing communities for tobacco control efforts in Massachusetts. American Journal of Public Health 2009, 99:470.
18. Mendez-Luck C.A., Yu H., Meng Y.Y., Jhawar M., Wallace S.P. Estimating health conditions for small areas: Asthma symptom prevalence for state legislative districts. Health Services Research 2007, 42:2389-2409.
19. Neubrand T.P.L., Breitkopf C.R., Rupp R., Breitkopf D., Rosenthal S.L. Factors associated with completion of the human papillomavirus vaccine series. Clinical Pediatrics 2009, 48:966-969.
20. Pruitt S.L., Schootman M. Geographic disparity, area poverty, and human papillomavirus vaccination. American Journal of Preventive Medicine 2010, 38:525-533.
21. Rabe-Hesketh S., Skrondal A. Multilevel modelling of complex survey data. Journal of the Royal Statistical Society: Series A (Statistics in Society) 2006, 169:805-827.
22. Rondy M., van Lier A., van de Kassteele J., Rust L., de Melker H. Determinants for HPV vaccine uptake in the Netherlands: A multilevel study. Vaccine 2010, 28:2070-2075.
23. Rosenthal S.L., Rupp R., Zimet G.D., Meza H.M., Loza M.L., Short M.B., et al. Uptake of HPV vaccine: Demographics, sexual history and values, parenting style, and vaccine attitudes. Journal of Adolescent Health 2008, 43:239-245.
24. Schneider K.L., Lapane K.L., Clark M.A., Rakowski W. Using small-area estimation to describe county-level disparities in mammography. Preventing Chronic Disease 2009, 6:A125.
25. Siegel P.Z., Frazier E.L., Mariolis P., Brackbill R.M., Smith C. Behavioral Risk Factor Surveillance, 1991: Monitoring progress toward the nation's year 2000 health objectives. Morbidity and Mortality Weekly Report Surveillance Summaries 1993, 42(SS-4):1-21.
26. U.S. Centers for Disease Control and Prevention. (2008a). Behavioral Risk Factor Surveillance System: 2008 summary data quality report. Retrieved September 2, 2011, from ftp://ftp.cdc.gov/pub/Data/Brfss/2008_Summary_Data_Quality_Report.pdf.
27. U. S. Centers for Disease Control and Prevention. (2008b). BRFSS Annual Survey Data: Survey data and documentation. Retrieved January 20, 2011, from http://www.cdc.gov/brfss/technical_infodata/surveydata/2008.htm.
28. U.S. Centers for Disease Control and Prevention. (2009). U.S. Census populations with bridged race categories. Retrieved January 20, 2011, from http://www.cdc.gov/nchs/nvss/bridged_race.htm.
29. U.S. Food and Drug Administration (2006). FDA licenses new vaccine for prevention of cervical cancer and other diseases in females caused by human papillomavirus. Retrieved January 20, 2011, from http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108666.htm.
30. Wong C.A., Berkowitz Z., Dorell C.G., Price R.A., Lee J., Saraiya M. Human papillomavirus vaccine uptake among 9- to 17-year-old girls. Cancer 2011, 117:5612-5620.
31. Yu H., Meng Y.Y., Mendez-Luck C.A., Jhawar M., Wallace S.P. Small-area estimation of health insurance coverage for California legislative districts. American Journal of Public Health 2007, 97:731-737.
32. Zimet G.D., Liddon N., Rosenthal S.L., Lazcano-Ponce E., Allen B. Chapter 24: Psychosocial aspects of vaccine acceptability. Vaccine 2006, 24(S3):201-209.